Clinical Trials on Pulmonary Atelectasis, Postoperative
Total 0 results
Nothing found
Sponsors and Collaborators
- CTC Bio, Inc.
- Medtronic Atrial Fibrillation Solutions
- Health Parametrics Inc.
- Rex Bionics Plc
- New York State Health Foundation
- Montreal Neurological Institute and Hospital
- Mitchell Scheiman
- Zahra Rabbani Khah
- Wushan County People's Hospital
- Marilia Medicine School
- Kawin Technology Share-holding Co., Ltd.
- Jeffrey Rudolph
- Jeffrey W. Clark, MD
- MingSight Pharmaceuticals Pty Limited
- Honda R and D Americas, Inc.
- John Granton
- European Network For Smoking and Tobacco Prevention
- The Third Hospital of Changsha
- Ionis Pharmaceuticals
- Northern California Melanoma Center
- View Full List
Medical Conditions
- Low Birthweight, Extremely (999 Grams or Less)
- Improved Vocal Fold Status
- Ketamine Treatment
- Moderate to Severe Functional Impairments
- Heart Defect, Congenital
- Idiopathic Gastric Stasis
- Radial Artery Catheterization
- Pediatric Anaplastic Large Cell Lymphoma
- Nutritional Edema
- Postmenopausal Diabetes
- Suspected Neonatal Encephalopathy
- Canthal Lines
- Myeloproliferative Disease
- Pertussis Immunisation
- Fecal Elastase-1 Test
- Periodontology
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Acute Necrotizing Encephalopathy
- Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social Pressure.
- Influenza and Other Novel Respiratory Viruses
- View Full List
Drug Interventions
- 200 µg doxorubicin-containing MNA
- Toripalimab plus Anlotinib
- Fludarabine
- Ombrabulin (AVE8062)
- AZD7798
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Levcromakalim
- Bendamustine
- Pentostatin
- Postoperative analgesia management
- Rifaximin
- Hydroxychloroquine
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- CKD-519
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Nimotuzumab
- Levobupivacaine, clonidine
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- ESK981
- View Full List
CROs by country
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in China
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Egypt
- Contract Research Organizations in France
- Contract Research Organizations in Ghana
- Contract Research Organizations in Hungary
- Contract Research Organizations in Ireland
- Contract Research Organizations in Italy
- Contract Research Organizations in Jordan
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Philippines
- Contract Research Organizations in Uganda
- CRO list by country